APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dapagliflozin Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dapagliflozin Tablets Industry Growth and Trends Forecast to 2032

Report ID 173982520128 December 2025114 pages

Choose your research edition.

Industry ResearchDapagliflozin Tablets Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Dapagliflozin Tablets Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Dapagliflozin Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dapagliflozin Tablets Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Dapagliflozin Tablets Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Dapagliflozin Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dapagliflozin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dapagliflozin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dapagliflozin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dapagliflozin Tablets include Addii Biotech, Aetos Pharma, Casca Remedies, Fawn Incorporation, Fibovil Pharma, Jabs Biotech, Rakshit Pharmaceuticals Limited, Zydus Healthcare and AstraZeneca Pharmaceuticals (China) Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dapagliflozin Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dapagliflozin Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dapagliflozin Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dapagliflozin Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dapagliflozin Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dapagliflozin Tablets Market by Company

Addii Biotech

Aetos Pharma

Casca Remedies

Fawn Incorporation

Fibovil Pharma

Jabs Biotech

Rakshit Pharmaceuticals Limited

Zydus Healthcare

AstraZeneca Pharmaceuticals (China) Co., Ltd.

Beijing Fuyuan Pharmaceutical Co., Ltd.

Beijing Shuanglu Pharmaceutical Co., Ltd.

Chengdu Beite Pharmaceutical Co., Ltd.

Jiangsu Hausen Pharmaceutical Group Co., Ltd.

Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.

Ningbo Minnova Tiankang Pharmaceutical Co., Ltd.

Shandong Lukang Pharmaceutical Co., Ltd.

Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.

Yiling Wanzhou International Pharmaceutical Co., Ltd.

Dapagliflozin Tablets Segment by Type

10mg

5mg

Dapagliflozin Tablets Segment by Application

Hospital

Clinic

Other

Dapagliflozin Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dapagliflozin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dapagliflozin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dapagliflozin Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dapagliflozin Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dapagliflozin Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mg Table 2. Major Company of 5mg Table 3. Global Dapagliflozin Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Dapagliflozin Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Dapagliflozin Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Dapagliflozin Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Dapagliflozin Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Dapagliflozin Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Dapagliflozin Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Dapagliflozin Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Dapagliflozin Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Dapagliflozin Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Dapagliflozin Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Dapagliflozin Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Dapagliflozin Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Dapagliflozin Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Dapagliflozin Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Dapagliflozin Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Dapagliflozin Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Dapagliflozin Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Dapagliflozin Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Dapagliflozin Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Dapagliflozin Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Dapagliflozin Tablets Industry Trends Table 25. Dapagliflozin Tablets Industry Drivers Table 26. Dapagliflozin Tablets Industry Opportunities and Challenges Table 27. Dapagliflozin Tablets Industry Restraints Table 28. Global Dapagliflozin Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Dapagliflozin Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Dapagliflozin Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Dapagliflozin Tablets Sales Share by Company (2021-2026) Table 32. Global Dapagliflozin Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Dapagliflozin Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Dapagliflozin Tablets Major Company Production Sites and Headquarters Table 35. Global Dapagliflozin Tablets Company, Product Type & Application Table 36. Global Dapagliflozin Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Dapagliflozin Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Dapagliflozin Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Dapagliflozin Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Dapagliflozin Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Dapagliflozin Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Dapagliflozin Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Dapagliflozin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Dapagliflozin Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Dapagliflozin Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Dapagliflozin Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Dapagliflozin Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Dapagliflozin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Dapagliflozin Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Dapagliflozin Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Dapagliflozin Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Dapagliflozin Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Dapagliflozin Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Dapagliflozin Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Dapagliflozin Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Dapagliflozin Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Dapagliflozin Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Dapagliflozin Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Dapagliflozin Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Dapagliflozin Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Dapagliflozin Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Dapagliflozin Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Dapagliflozin Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Dapagliflozin Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Dapagliflozin Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Dapagliflozin Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Dapagliflozin Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Dapagliflozin Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Dapagliflozin Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Addii Biotech Company Information Table 72. Addii Biotech Business Overview Table 73. Addii Biotech Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Addii Biotech Dapagliflozin Tablets Product Portfolio Table 75. Addii Biotech Recent Development Table 76. Aetos Pharma Company Information Table 77. Aetos Pharma Business Overview Table 78. Aetos Pharma Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Aetos Pharma Dapagliflozin Tablets Product Portfolio Table 80. Aetos Pharma Recent Development Table 81. Casca Remedies Company Information Table 82. Casca Remedies Business Overview Table 83. Casca Remedies Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Casca Remedies Dapagliflozin Tablets Product Portfolio Table 85. Casca Remedies Recent Development Table 86. Fawn Incorporation Company Information Table 87. Fawn Incorporation Business Overview Table 88. Fawn Incorporation Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Fawn Incorporation Dapagliflozin Tablets Product Portfolio Table 90. Fawn Incorporation Recent Development Table 91. Fibovil Pharma Company Information Table 92. Fibovil Pharma Business Overview Table 93. Fibovil Pharma Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Fibovil Pharma Dapagliflozin Tablets Product Portfolio Table 95. Fibovil Pharma Recent Development Table 96. Jabs Biotech Company Information Table 97. Jabs Biotech Business Overview Table 98. Jabs Biotech Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Jabs Biotech Dapagliflozin Tablets Product Portfolio Table 100. Jabs Biotech Recent Development Table 101. Rakshit Pharmaceuticals Limited Company Information Table 102. Rakshit Pharmaceuticals Limited Business Overview Table 103. Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Product Portfolio Table 105. Rakshit Pharmaceuticals Limited Recent Development Table 106. Zydus Healthcare Company Information Table 107. Zydus Healthcare Business Overview Table 108. Zydus Healthcare Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Zydus Healthcare Dapagliflozin Tablets Product Portfolio Table 110. Zydus Healthcare Recent Development Table 111. AstraZeneca Pharmaceuticals (China) Co., Ltd. Company Information Table 112. AstraZeneca Pharmaceuticals (China) Co., Ltd. Business Overview Table 113. AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 115. AstraZeneca Pharmaceuticals (China) Co., Ltd. Recent Development Table 116. Beijing Fuyuan Pharmaceutical Co., Ltd. Company Information Table 117. Beijing Fuyuan Pharmaceutical Co., Ltd. Business Overview Table 118. Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 120. Beijing Fuyuan Pharmaceutical Co., Ltd. Recent Development Table 121. Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information Table 122. Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview Table 123. Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 125. Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Development Table 126. Chengdu Beite Pharmaceutical Co., Ltd. Company Information Table 127. Chengdu Beite Pharmaceutical Co., Ltd. Business Overview Table 128. Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 130. Chengdu Beite Pharmaceutical Co., Ltd. Recent Development Table 131. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information Table 132. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview Table 133. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 135. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Development Table 136. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information Table 137. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Business Overview Table 138. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 140. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Development Table 141. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Company Information Table 142. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Business Overview Table 143. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 145. Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Recent Development Table 146. Shandong Lukang Pharmaceutical Co., Ltd. Company Information Table 147. Shandong Lukang Pharmaceutical Co., Ltd. Business Overview Table 148. Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 150. Shandong Lukang Pharmaceutical Co., Ltd. Recent Development Table 151. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information Table 152. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview Table 153. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 155. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Development Table 156. Yiling Wanzhou International Pharmaceutical Co., Ltd. Company Information Table 157. Yiling Wanzhou International Pharmaceutical Co., Ltd. Business Overview Table 158. Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio Table 160. Yiling Wanzhou International Pharmaceutical Co., Ltd. Recent Development Table 161. North America Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. North America Dapagliflozin Tablets Sales by Country (2021-2026) & (K Units) Table 163. North America Dapagliflozin Tablets Sales Market Share by Country (2021-2026) Table 164. North America Dapagliflozin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 165. North America Dapagliflozin Tablets Sales Market Share Forecast by Country (2027-2032) Table 166. North America Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. North America Dapagliflozin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 168. North America Dapagliflozin Tablets Market Share by Country (2021-2026) Table 169. North America Dapagliflozin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. North America Dapagliflozin Tablets Market Share Forecast by Country (2027-2032) Table 171. Europe Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Europe Dapagliflozin Tablets Sales by Country (2021-2026) & (K Units) Table 173. Europe Dapagliflozin Tablets Sales Market Share by Country (2021-2026) Table 174. Europe Dapagliflozin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 175. Europe Dapagliflozin Tablets Sales Market Share Forecast by Country (2027-2032) Table 176. Europe Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Europe Dapagliflozin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 178. Europe Dapagliflozin Tablets Market Share by Country (2021-2026) Table 179. Europe Dapagliflozin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Europe Dapagliflozin Tablets Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Dapagliflozin Tablets Sales by Country (2021-2026) & (K Units) Table 183. Asia-Pacific Dapagliflozin Tablets Sales Market Share by Country (2021-2026) Table 184. Asia-Pacific Dapagliflozin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 185. Asia-Pacific Dapagliflozin Tablets Sales Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Dapagliflozin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 188. Asia-Pacific Dapagliflozin Tablets Market Share by Country (2021-2026) Table 189. Asia-Pacific Dapagliflozin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Asia-Pacific Dapagliflozin Tablets Market Share Forecast by Country (2027-2032) Table 191. Latin America Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Latin America Dapagliflozin Tablets Sales by Country (2021-2026) & (K Units) Table 193. Latin America Dapagliflozin Tablets Sales Market Share by Country (2021-2026) Table 194. Latin America Dapagliflozin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 195. Latin America Dapagliflozin Tablets Sales Market Share Forecast by Country (2027-2032) Table 196. Latin America Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Latin America Dapagliflozin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 198. Latin America Dapagliflozin Tablets Market Share by Country (2021-2026) Table 199. Latin America Dapagliflozin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Latin America Dapagliflozin Tablets Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Dapagliflozin Tablets Sales by Country (2021-2026) & (K Units) Table 203. Middle East and Africa Dapagliflozin Tablets Sales Market Share by Country (2021-2026) Table 204. Middle East and Africa Dapagliflozin Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 205. Middle East and Africa Dapagliflozin Tablets Sales Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Dapagliflozin Tablets Market Size by Country (2021-2026) & (US$ Million) Table 208. Middle East and Africa Dapagliflozin Tablets Market Share by Country (2021-2026) Table 209. Middle East and Africa Dapagliflozin Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Middle East and Africa Dapagliflozin Tablets Market Share Forecast by Country (2027-2032) Table 211. Key Raw Materials Table 212. Raw Materials Key Suppliers Table 213. Dapagliflozin Tablets Distributors List Table 214. Dapagliflozin Tablets Customers List Table 215. Research Programs/Design for This Report Table 216. Authors List of This Report Table 217. Secondary Sources Table 218. Primary Sources List of Figures Figure 1. Dapagliflozin Tablets Image Figure 2. Global Dapagliflozin Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dapagliflozin Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Dapagliflozin Tablets Sales (2021-2032) & (K Units) Figure 5. 10mg Image Figure 6. Global 10mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 5mg Image Figure 8. Global 5mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Dapagliflozin Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Dapagliflozin Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Dapagliflozin Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Dapagliflozin Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Dapagliflozin Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Dapagliflozin Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Dapagliflozin Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Dapagliflozin Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Dapagliflozin Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Dapagliflozin Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Dapagliflozin Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Dapagliflozin Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Dapagliflozin Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Dapagliflozin Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Dapagliflozin Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Dapagliflozin Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Dapagliflozin Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Dapagliflozin Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Dapagliflozin Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Dapagliflozin Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Dapagliflozin Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Dapagliflozin Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Dapagliflozin Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Dapagliflozin Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Dapagliflozin Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Dapagliflozin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Dapagliflozin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Dapagliflozin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Dapagliflozin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Dapagliflozin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Dapagliflozin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Dapagliflozin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Dapagliflozin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Dapagliflozin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Dapagliflozin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Dapagliflozin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Dapagliflozin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Dapagliflozin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Dapagliflozin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Dapagliflozin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Dapagliflozin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Dapagliflozin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Dapagliflozin Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Dapagliflozin Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Dapagliflozin Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Dapagliflozin Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Dapagliflozin Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 5mg
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Addii Biotech
  • Aetos Pharma
  • Casca Remedies
  • Fawn Incorporation
  • Fibovil Pharma
  • Jabs Biotech
  • Rakshit Pharmaceuticals Limited
  • Zydus Healthcare
  • AstraZeneca Pharmaceuticals (China) Co., Ltd.
  • Beijing Fuyuan Pharmaceutical Co., Ltd.
  • Beijing Shuanglu Pharmaceutical Co., Ltd.
  • Chengdu Beite Pharmaceutical Co., Ltd.
  • Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  • Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
  • Ningbo Minnova Tiankang Pharmaceutical Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd.
  • Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  • Yiling Wanzhou International Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dapagliflozin Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dapagliflozin Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dapagliflozin Tablets Market by Type
  6. 1.3.1 10mg
  7. 1.3.2 5mg
  8. 1.4 Global Dapagliflozin Tablets Market Size by Type
  9. 1.4.1 Global Dapagliflozin Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Dapagliflozin Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Dapagliflozin Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Dapagliflozin Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Dapagliflozin Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Dapagliflozin Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Dapagliflozin Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Dapagliflozin Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dapagliflozin Tablets Industry Trends
  2. 2.2 Dapagliflozin Tablets Industry Drivers
  3. 2.3 Dapagliflozin Tablets Industry Opportunities and Challenges
  4. 2.4 Dapagliflozin Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dapagliflozin Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Dapagliflozin Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Dapagliflozin Tablets Price (2021-2026)
  4. 3.4 Global Dapagliflozin Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dapagliflozin Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Dapagliflozin Tablets Company, Product Type & Application
  7. 3.7 Global Dapagliflozin Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dapagliflozin Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dapagliflozin Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dapagliflozin Tablets Tier 1, Tier 2, and Tier 3
4 Dapagliflozin Tablets Regional Status and Outlook
  1. 4.1 Global Dapagliflozin Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dapagliflozin Tablets Historic Market Size by Region
  3. 4.2.1 Global Dapagliflozin Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dapagliflozin Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dapagliflozin Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dapagliflozin Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Dapagliflozin Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dapagliflozin Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dapagliflozin Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dapagliflozin Tablets by Application
  1. 5.1 Dapagliflozin Tablets Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Dapagliflozin Tablets Market Size by Application
  6. 5.2.1 Global Dapagliflozin Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Dapagliflozin Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Dapagliflozin Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Dapagliflozin Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Dapagliflozin Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Dapagliflozin Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Dapagliflozin Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Dapagliflozin Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Addii Biotech
  2. 6.1.1 Addii Biotech Company Information
  3. 6.1.2 Addii Biotech Business Overview
  4. 6.1.3 Addii Biotech Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Addii Biotech Dapagliflozin Tablets Product Portfolio
  6. 6.1.5 Addii Biotech Recent Developments
  7. 6.2 Aetos Pharma
  8. 6.2.1 Aetos Pharma Company Information
  9. 6.2.2 Aetos Pharma Business Overview
  10. 6.2.3 Aetos Pharma Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Aetos Pharma Dapagliflozin Tablets Product Portfolio
  12. 6.2.5 Aetos Pharma Recent Developments
  13. 6.3 Casca Remedies
  14. 6.3.1 Casca Remedies Company Information
  15. 6.3.2 Casca Remedies Business Overview
  16. 6.3.3 Casca Remedies Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Casca Remedies Dapagliflozin Tablets Product Portfolio
  18. 6.3.5 Casca Remedies Recent Developments
  19. 6.4 Fawn Incorporation
  20. 6.4.1 Fawn Incorporation Company Information
  21. 6.4.2 Fawn Incorporation Business Overview
  22. 6.4.3 Fawn Incorporation Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fawn Incorporation Dapagliflozin Tablets Product Portfolio
  24. 6.4.5 Fawn Incorporation Recent Developments
  25. 6.5 Fibovil Pharma
  26. 6.5.1 Fibovil Pharma Company Information
  27. 6.5.2 Fibovil Pharma Business Overview
  28. 6.5.3 Fibovil Pharma Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Fibovil Pharma Dapagliflozin Tablets Product Portfolio
  30. 6.5.5 Fibovil Pharma Recent Developments
  31. 6.6 Jabs Biotech
  32. 6.6.1 Jabs Biotech Company Information
  33. 6.6.2 Jabs Biotech Business Overview
  34. 6.6.3 Jabs Biotech Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jabs Biotech Dapagliflozin Tablets Product Portfolio
  36. 6.6.5 Jabs Biotech Recent Developments
  37. 6.7 Rakshit Pharmaceuticals Limited
  38. 6.7.1 Rakshit Pharmaceuticals Limited Company Information
  39. 6.7.2 Rakshit Pharmaceuticals Limited Business Overview
  40. 6.7.3 Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Rakshit Pharmaceuticals Limited Dapagliflozin Tablets Product Portfolio
  42. 6.7.5 Rakshit Pharmaceuticals Limited Recent Developments
  43. 6.8 Zydus Healthcare
  44. 6.8.1 Zydus Healthcare Company Information
  45. 6.8.2 Zydus Healthcare Business Overview
  46. 6.8.3 Zydus Healthcare Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zydus Healthcare Dapagliflozin Tablets Product Portfolio
  48. 6.8.5 Zydus Healthcare Recent Developments
  49. 6.9 AstraZeneca Pharmaceuticals (China) Co., Ltd.
  50. 6.9.1 AstraZeneca Pharmaceuticals (China) Co., Ltd. Company Information
  51. 6.9.2 AstraZeneca Pharmaceuticals (China) Co., Ltd. Business Overview
  52. 6.9.3 AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca Pharmaceuticals (China) Co., Ltd. Dapagliflozin Tablets Product Portfolio
  54. 6.9.5 AstraZeneca Pharmaceuticals (China) Co., Ltd. Recent Developments
  55. 6.10 Beijing Fuyuan Pharmaceutical Co., Ltd.
  56. 6.10.1 Beijing Fuyuan Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Beijing Fuyuan Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Beijing Fuyuan Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  60. 6.10.5 Beijing Fuyuan Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Beijing Shuanglu Pharmaceutical Co., Ltd.
  62. 6.11.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  66. 6.11.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Chengdu Beite Pharmaceutical Co., Ltd.
  68. 6.12.1 Chengdu Beite Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Chengdu Beite Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Chengdu Beite Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  72. 6.12.5 Chengdu Beite Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  74. 6.13.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
  75. 6.13.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview
  76. 6.13.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Dapagliflozin Tablets Product Portfolio
  78. 6.13.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments
  79. 6.14 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
  80. 6.14.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  84. 6.14.5 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd.
  86. 6.15.1 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  90. 6.15.5 Ningbo Minnova Tiankang Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Shandong Lukang Pharmaceutical Co., Ltd.
  92. 6.16.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Shandong Lukang Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Shandong Lukang Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  96. 6.16.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  98. 6.17.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  102. 6.17.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Yiling Wanzhou International Pharmaceutical Co., Ltd.
  104. 6.18.1 Yiling Wanzhou International Pharmaceutical Co., Ltd. Company Information
  105. 6.18.2 Yiling Wanzhou International Pharmaceutical Co., Ltd. Business Overview
  106. 6.18.3 Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Yiling Wanzhou International Pharmaceutical Co., Ltd. Dapagliflozin Tablets Product Portfolio
  108. 6.18.5 Yiling Wanzhou International Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Dapagliflozin Tablets Sales by Country
  2. 7.1.1 North America Dapagliflozin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dapagliflozin Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Dapagliflozin Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dapagliflozin Tablets Market Size by Country
  6. 7.2.1 North America Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dapagliflozin Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Dapagliflozin Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dapagliflozin Tablets Sales by Country
  2. 8.1.1 Europe Dapagliflozin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dapagliflozin Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Dapagliflozin Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dapagliflozin Tablets Market Size by Country
  6. 8.2.1 Europe Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dapagliflozin Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dapagliflozin Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dapagliflozin Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Dapagliflozin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dapagliflozin Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dapagliflozin Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dapagliflozin Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dapagliflozin Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dapagliflozin Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dapagliflozin Tablets Sales by Country
  2. 10.1.1 South America Dapagliflozin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dapagliflozin Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Dapagliflozin Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dapagliflozin Tablets Market Size by Country
  6. 10.2.1 South America Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dapagliflozin Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Dapagliflozin Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dapagliflozin Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Dapagliflozin Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dapagliflozin Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dapagliflozin Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dapagliflozin Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Dapagliflozin Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dapagliflozin Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dapagliflozin Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dapagliflozin Tablets Value Chain Analysis
  2. 12.1.1 Dapagliflozin Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dapagliflozin Tablets Production Mode & Process
  7. 12.2 Dapagliflozin Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dapagliflozin Tablets Distributors
  10. 12.2.3 Dapagliflozin Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst